- Sort by:
- Browse by:
- Free
- podium video
- slides video
- audio + slides
- All slides included
Opening Video
Opening Remarks
Margaret Foti
American Association for Cancer Research, Philadelphia, PA
President's Remarks
Carlos L. Arteaga
Vanderbilt-Ingram Cancer Center, Nashville, TN
- Free
- podium video
- slides video
- audio + slides
- All slides included
2015 AACR Distinguished Public Service Award Presentation
Recipient: Siddharta Mukherjee
Columbia University, New York, NY
- Free
- podium video
- slides video
- audio + slides
- All slides included
2015 AACR Distinguished Public Service Award Presentation
Recipient (Video): U.S. Senator Robert P. Casey, Jr. [D-PA]
- Free
- podium video
- slides video
- audio + slides
- All slides included
Ninth Annual AACR Team Science Award Presentation
Recipients: The Designing AR Inhibitors Team - Charles L. Sawyers, Michael E. Jung, and Howard I. Scher
Memorial Sloan Kettering Cancer Center, New York, NY; University of California, Los Angeles, CA; Memorial Sloan Kettering Cancer Center, New York, NY
- Free
- podium video
- slides video
- audio + slides
- All slides included
Twelfth Annual AACR Award for Lifetime Achievement in Cancer Research Presentation
Recipient: Mario R. Capecchi
University of Utah, Salt Lake City, UT
- Free
- podium video
- slides video
- audio + slides
- All slides included
2015 AACR Distinguished Public Service Award Presentation
Recipient: Miri Ziv
Israel Cancer Association, Givatayim, Israel
- Free
- podium video
- slides video
- audio + slides
- All slides included
Recognition of the Fellows of the AACR Academy
Margaret Foti
American Association for Cancer Research, Philadelphia, PA
- Free
- podium video
- slides video
- audio + slides
- All slides included
Ninth Annual AACR Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research Presentation
Recipient: Donald S. Coffey
Johns Hopkins School of Medicine, Baltimore, MD
- Free
- podium video
- slides video
- audio + slides
- All slides included
2015 AACR Distinguished Public Service Award Presentation
Recipient: Richard Pazdur
U.S. Food and Drug Administration, Silver Spring, MD
- Free
- podium video
- slides video
- audio + slides
- All slides included
In Memoriam
Arthur C. Upton
Emmanuel Farber
Lee Wattenberg
Eddie Reed
Kirk L. Landon
June L. Biedler
Emmanuel Farber
Lee Wattenberg
Eddie Reed
Kirk L. Landon
June L. Biedler
- Free
- podium video
- slides video
- audio + slides
- All slides included
Announcement of AACR-June L. Biedler Cancer Journalism Awards
Announcement of AAACR-June L. Biedler Scholar-in-Training Awards
Announcement of AAACR-June L. Biedler Scholar-in-Training Awards
Margaret Foti
American Association for Cancer Research, Philadelphia, PA
- Free
- podium video
- slides video
- audio + slides
- All slides included
Closing Remarks
Announcement of AACR NextGen Grants for Transformative Cancer Research
Announcement of AACR NextGen Grants for Transformative Cancer Research
Carlos L. Arteaga
Vanderbilt-Ingram Cancer Center, Nashville, TN
- Free
- podium video
- slides video
- audio + slides
- All slides included
Insights from cancer genomes into the mutational processes underlying cancer development
Michael R. Stratton
Wellcome Trust Sanger Inst., Cambridge, United Kingdom
- Free
- podium video
- slides video
- audio + slides
- All slides included
Engineering the cancer genome
Tyler Jacks
David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, United States
- Free
- podium video
- slides video
- audio + slides
- All slides included
Above the genome: The epigenome and its biology and translational potential
Stephen B. Baylin
Johns Hopkins University School of Medicine, Baltimore, MD, United States
- Free
- podium video
- slides video
- audio + slides
- All slides included
Using genomics to personalize cancer immunotherapy
Robert D. Schreiber
Washington University School of Medicine, St. Louis, MO, United States
- Free
- podium video
- slides video
- audio + slides
- All slides included
Phase III study of pembrolizumab (MK-3475) versus ipilimumab in patients with ipilimumab-naive advanced melanoma
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, United States
- Free
- podium video
- slides video
- audio + slides
- All slides included
Discussant: Phase III study of pembrolizumab (MK-3475) versus ipilimumab (Ribaset al.)
Jedd D. Wolchok
Memorial Sloan Kettering Cancer Center, New York, NY, United States
- Free
- podium video
- slides video
- audio + slides
- All slides included
Dual targeting of BCR-ABL with ABL001: A novel potent allosteric ABL kinase inhibitor in combination with nilotinib suppresses the emergence of disease resistance in models of CML
William R. Sellers
Novartis Insts. for BioMedical Research, Cambridge, MA, United States
- Free
- slides video
- audio + slides
- All slides included
Clinical safety and efficacy of pembrolizumab (MK-3475) in patients with malignant pleural mesothelioma: Preliminary results from KEYNOTE-028
Evan W Alley
University of Pennsylvania, Philadelphia, PA, United States
- Free
- slides video
- audio + slides
- All slides included
Efficacy of pembrolizumab (MK-3475) and relationship with PD-L1 expression in patients with non-small cell lung cancer: Findings from KEYNOTE-001)
Edward B. Garon
David Geffen School of Medicine at UCLA, Los Angeles, CA, United States
- Free
- slides video
- audio + slides
- All slides included
Discussant
D. Ross Camidge
University of Colorado Denver, Aurora, CO, United States
- Free
- slides video
- audio + slides
- All slides included
Safety and feasibility of chimeric antigen receptor modified T cells directed against mesothelin (CART-meso) in patients with mesothelin expressing cancers
Janos L Tanyi
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States
- Free
- slides video
- audio + slides
- All slides included
Discussant
Michel Sadelain
Memorial Sloan Kettering Cancer Center, New York, NY, United States
- Free
- slides video
- audio + slides
- All slides included
A phase I/IIa study of IMCgp100: Partial and complete durable responses with a novel first-in-class immunotherapy for advanced melanoma
Mark R Middleton
University of Oxford, Oxford, United Kingdom